Glucagon-like peptide-1
US$ 24.68
tirzepatide change taste How GLP-1 Medications are Rewiring Palates & What it Means for F&B From Ozempic to Mounjaro, discover
Description
Stopping therapy is often followed by weight regain
Nanuka Tsibadze and colleagues noted, GLP-1s may be a promising adjunct for patients with PsA and comorbid obesity or type 2 diabetes
Constipation is another early signal
NICE guidance on GLP-1 receptor agonists (NG28 for diabetes, TA875 for weight management) acknowledges these gastrointestinal effects and recommends that healthcare professionals counsel patients about expected side effects and management strategies before initiating treatment
PMCID: PMC12808897
